Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS von List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A

Volltext

Low Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicente... von Shammo, Jamile, Gajra, Ajeet, Patel, Yogesh, Tomazos, Ioannis, Kish, Jonathan, Hill, Anita, Sierra, J. Rafael, Araten, David

Volltext

Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS von List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A

Volltext

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome von Sokol, L, Cripe, L, Kantarjian, H, Sekeres, M A, Parmar, S, Greenberg, P, Goldberg, S L, Bhushan, V, Shammo, J, Hohl, R, Verma, A, Garcia-Manero, G, Li, Y-P, Lowe, A, Zhu, J, List, A F

Volltext

Safety and Efficacy of Romiplostim in Patients With Lower-Risk Myelodysplastic Syndrome and Thrombocytopenia von KANTARJIAN, Hagop, FENAUX, Pierre, SHAMMO, Jamile, SIEGEL, Robert, KUOLUNG HU, FRANKLIN, Janet, BERGER, Dietmar P, SEKERES, Mikkael A, BECKER, Pamela S, BORUCHOV, Adam, BOWEN, David, HELLSTROM-LINDBERG, Eva, LARSON, Richard A, LYONS, Roger M, MUUS, Petra

Volltext

Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria von Dingli, David, De Castro Iii, Carlos, Koprivnikar, Jamie, Kulasekararaj, Austin, Maciejewski, Jaroslaw, Mulherin, Brian, Panse, Jens, Pullarkat, Vinod, Röth, Alexander, Shammo, Jamile, Terriou, Louis, Weitz, Ilene, Yermilov, Irina, Gibbs, Sarah, Broder, Michael, Beenhouwer, David, Kuter, David

Volltext

A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis von Vannucchi, Alessandro M, Kantarjian, Hagop M, Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A, Sarlis, Nicholas J, Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan

Volltext

Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I von Verstovsek, Srdan, Mesa, Ruben A, Gotlib, Jason, Levy, Richard S, Gupta, Vikas, DiPersio, John F, Catalano, John V, Deininger, Michael W N, Miller, Carole B, Silver, Richard T, Talpaz, Moshe, Winton, Elliott F, Harvey, Jr, Jimmie H, Arcasoy, Murat O, Hexner, Elizabeth O, Lyons, Roger M, Raza, Azra, Vaddi, Kris, Sun, William, Peng, Wei, Sandor, Victor, Kantarjian, Hagop

Volltext

TARGETING RNA EPIGENETICS TO PREDICT AND OVERCOME DRUG RESISTANCE IN MDS AND AML von Cheng, J., Wood, S., Willbanks, A., Tang, D., Degenstein, L., Arber, D., Oakes, S., Shammo, J., Odenike, T., Stock, W., Larson, R., Joachimiak, A., Stevens, R.

Volltext

First two cases of immune hemolytic anemia associated with ceftizoxime von Shammo, J.M., Calhoun, B., Mauer, A.M., Hoffman, P.C., Baron, J.M., Baron, B.W.

Volltext

Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions von Chalmers, Anna W, Shammo, Jamile M

Volltext

Erratum: Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDS von List, A F, Bennett, J M, Sekeres, M A, Skikne, B, Fu, T, Shammo, J M, Nimer, S D, Knight, R D, Giagounidis, A

Volltext

Etoposide and cytarabine as an effective and safe cytoreductive regimen for relapsed or refractory acute myeloid leukemia von Nair, G., Karmali, R., Gregory, S. A., Shammo, J. M., Fung, H. C., Jimenez, A., Venugopal, P., Larson, M. L.

Volltext

Randomized, dose-escalation study of the p38[alpha] MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome von Sokol, L, Cripe, L, Kantarjian, H, Sekeres, M A, Parmar, S, Greenberg, P, Goldberg, S L, Bhushan, V, Shammo, J, Hohl, R, Verma, A, Garcia-manero, G, Li, Y-p, Lowe, A, Zhu, J, List, A F

Volltext

Clinical characteristics and outcomes according to age in lenalidomide-treated patients with RBC transfusion-dependent lower-risk MDS and del(5q) von Fenaux, Pierre, Giagounidis, Aristoteles, Selleslag, Dominik, Beyne-Rauzy, Odile, Mittelman, Moshe, Muus, Petra, Nimer, Stephen D, Hellström-Lindberg, Eva, Powell, Bayard L, Guerci-Bresler, Agnes, Sekeres, Mikkael A, Deeg, H Joachim, Del Cañizo, Consuelo, Greenberg, Peter L, Shammo, Jamile M, Skikne, Barry, Yu, Xujie, List, Alan F

Volltext

An analysis of high ferritin levels before allogeneic hematopoietic cell transplantation (AlloHCT): A retrospective study to evaluate prognostic factors in patients (pts) undergoin... von Hashmi, S., Rich, E. S., Basu, S., Maciejewski, J. J., Nathan, S., Venugopal, P., Gregory, S. A., Fung, H. C., Shammo, J. M.

Volltext

Safety analysis of radioimmunotherapy (RIT) in patients with relapsed or refractory low grade, follicular or transformed non-Hodgkin's lymphoma and mantle cell lymphoma based on ag... von Braun, E., Katz, D., Venugopal, P., Larson, M., Shammo, J., Fung, H., Gregory, S.

Volltext

Use of a tumor-cell enrichment column for the enhanced detection of minimal residual disease in the BM or apheresis peripheral blood transplant products of breast-cancer patients von Shammo, J.M., Smith, S.L., Bennett, M.V., Lee, H.W., Ostrander, A., Ross, A.A., Williams, S.F.

Volltext

A case report of sarcoma regression in a patient with MDS treated with lenalidomide von Shammo, J. M., Kassar, M., Robin, I., Knight, R.

Volltext

Multicenter analysis of 81 solid organ transplant (SOT) recipients with posttransplantation lymphoproliferative disease (PTLD): Examination of survival and prognostic factors von Evens, A. M., David, K. A., Helenowski, I., Kircher, S. M., Mauro, L., Gimelfarb, A., Hattersley, E., Shammo, J. M., Smith, S. E., Smith, S. M.

Volltext